Status:

UNKNOWN

Towards Painless Colonoscopy

Lead Sponsor:

Maria Sklodowska-Curie National Research Institute of Oncology

Collaborating Sponsors:

Centre of Postgraduate Medical Education

Conditions:

Colorectal Cancer

Eligibility:

All Genders

Phase:

NA

Brief Summary

One of the major barriers to CRC screening participation is a negative perception of colonoscopy as a painful and unpleasant procedure. Previously, by monitoring patient-reported outcomes as one of th...

Detailed Description

Background and study rationale: Colorectal cancer (CRC) is the second leading cause of death from cancer in Europe. Several modalities of CRC screening exist, with each screening modality including c...

Eligibility Criteria

Inclusion

  • Endoscopists contributing to Polish Colonoscopy Screening Program
  • Endoscopists classified as underperformers and average performers, i.e. endoscopists performing above the adjusted mean rate of painful colonoscopies (with high adjusted painful colonoscopy rate), outside of confidence interval of 99% based on the number of performed colonoscopies, and performing inside the confidence interval of 99%, respectively.
  • Colonoscopy volume of at least 100 colonoscopies/year for at least 2 years prior to the study inclusion

Exclusion

  • Endoscopists from the PCSP coordinating centre
  • Endoscopists who have participated in the first phase of the study
  • Endoscopists classified as overperformers, i.e. performing below the adjusted mean rate of painful colonoscopies (with high adjusted painful colonoscopy rate), outside of confidence interval of 99% based on the number of performed colonoscopies.

Key Trial Info

Start Date :

November 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2021

Estimated Enrollment :

64 Patients enrolled

Trial Details

Trial ID

NCT04093687

Start Date

November 1 2019

End Date

July 1 2021

Last Update

September 18 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Maria Sklodowska-Curie Institute - Oncology Center

Warsaw, Poland